KCAT19 T cells
/ University College London
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 12, 2026
KCAT19: Allogeneic T Cells Expressing T Cell Receptor-KDEL and the Chimeric Antigen Receptor CAT19 for the Treatment of Advanced CD19+ Malignancies
(clinicaltrials.gov)
- P1 | N=12 | Recruiting | Sponsor: University College, London | Not yet recruiting ➔ Recruiting | Trial completion date: Nov 2034 ➔ Feb 2040 | Trial primary completion date: Nov 2024 ➔ Feb 2027
Enrollment open • Trial completion date • Trial primary completion date • Hematological Malignancies • Oncology
May 26, 2022
KCAT19: Allogeneic T Cells Expressing T Cell Receptor-KDEL and the Chimeric Antigen Receptor CAT19 for the Treatment of Advanced CD19+ Malignancies
(clinicaltrials.gov)
- P1 | N=12 | Not yet recruiting | Sponsor: University College, London
New P1 trial • Hematological Malignancies • Oncology • CD19
1 to 2
Of
2
Go to page
1